Medical Cannabis for Menopause — Switzerland 2026
HRT is not suitable for every woman. Cannabinoids target several menopause symptoms — much cheaper for members.
In menopause, oestrogen and anandamide (endogenous cannabinoid) fluctuate in parallel. This explains hot flashes, sleep issues, mood swings and joint pain. Dahlgren 2022 (n=258): 79 % of peri-/postmenopausal cannabis users report symptom relief. HRT contraindications (BRCA, thrombosis) make cannabis particularly relevant. CannabisClub members: 50 CHF flat instead of 190.
What the studies show
Dahlgren 2022 (n=258): 79 % of peri-/postmenopausal women report cannabis-based relief of sleep, mood, pain.
Reynolds 2023 (survey, n=1,000): >50 % use cannabis for menopause symptoms; CBD dominant, THC micro-doses as add-on.
Symptom-oriented use
Hot flashes/night sweats: CBD 25–50 mg evening + THC 2.5 mg evening — helps indirectly via sleep quality.
Sleep: THC 2.5–5 mg 30 min before bed, CBD 25 mg for calm.
Cannabis or HRT?
HRT remains standard for marked vasomotor symptoms without contraindication.
In HRT contraindication (breast cancer, BRCA, VTE) cannabis is a documented alternative.
Save as a CannabisClub member
Gynecological cannabis consultations cost 190–250 CHF. Members: 50 CHF flat, titration plan included. Registration free.
FAQ
Is cannabis an HRT alternative?
Not a 1:1 replacement. Good option in HRT contraindication or when HRT only partially works (sleep, mood).
What does membership save?
50 CHF instead of 190 CHF per consultation. Registration free.
Does insurance cover it?
Rarely — menopause is not a standard art. 71a indication. Usually out of pocket.
Cannabis for Menopause — Prescription Switzerland 2026 (Members 50 CHF)